Chem Log · 1142 Labs: Tomorrow's Solutions Today

Protocol Series 1 · Primary Research Compounds

Core Compounds

The primary substances of the 1142 research program. Each studied systematically across multiple sessions with documented observations.

COMPOUND-001 · SEROTONERGIC

LSD-25

Lysergic acid diethylamide · C₂₀H₂₅N₃O

🔬

The foundational compound of 1142. First documented in the December 22, 2019 epiphany — a 12-hour solo session beginning at 11:42 PM. Studied extensively across the Brainstorm Nights protocol in combination with low-dose methylphenidate. Key discoveries include LSD as a Memory Archive (Feb 2022) and enhanced creative data capture under synergistic conditions.

Research Focus

MEMORY ARCHIVE CREATIVE SYNERGY TRAUMA PROCESSING BRAINSTORM NIGHTS RITUAL ANCHOR

12h

DURATION

5+

PAPERS

2019

FIRST LOG

COMPOUND-002 · STIMULANT

Methylphenidate

Ritalin / Biphentin · C₁₄H₁₉NO₂

💊

The cornerstone of 1142 research. Five-paper MPH Series published 2020–2022. Core findings: synergy with psychedelics (MPH-001), paradoxical IQ reduction at certain thresholds (MPH-002), the Ritalin Method harm-reduction protocol (MPH-003), perceptual expansion at saturation (MPH-004), and the Oxidized Theory (MPH-005/June 2021). The Blue Meth War narrative centers on stimulant cognitive sovereignty.

MPH SERIES · 5 PAPERS OXIDIZED THEORY IQ THRESHOLD HARM REDUCTION COGNITIVE SPEED

5

PAPERS

2020

SERIES START

Rx

PRESCRIBED

COMPOUND-003 · SEROTONERGIC

Psilocybin

Magic mushrooms · C₁₂H₁₇N₂O₄P

🍄

Documented under CS-004. Key finding: cognitive flexibility gains persisting 4–6 weeks post high-dose session, measured via structured cognitive battery. Studied for neuroplasticity applications specific to neurodivergent cognition. Cross-referenced with LSD sessions to map overlapping and divergent phenomenological profiles.

CS-004 NEUROPLASTICITY COGNITIVE FLEXIBILITY NEURODIVERGENT FOCUS

4-6w

PERSISTENCE

CS-004

STUDY ID

2022

FIRST LOG

COMPOUND-004 · TRYPTAMINE

DMT

Dimethyltryptamine · C₁₂H₁₆N₂

🌀

CS-003 study: Entity Contact phenomenology. Cross-referenced reports across multiple sessions for pattern consistency — structural analysis of communication patterns, geometric consistencies, and emotional tone profiles. The most technically challenging documentation in the 1142 archive due to brevity of state and post-session memory compression.

CS-003 ENTITY CONTACT PHENOMENOLOGY PATTERN ANALYSIS

15m

DURATION

CS-003

STUDY ID

∞

SUBJECTIVE

Protocol Series 2 · Secondary Compounds

Studied Substances

Published January 2024. The complete archive of every substance analyzed by 1142 Labs across five years of independent research.

Compound	Class	Study Period	Primary Finding / Protocol	Status
MDMA 3,4-methylenedioxymethamphetamine	Entactogen	2020–2022	Empathy enhancement cross-referenced with autism social cognition studies. Documented positive outcomes in interpersonal processing and emotional accessibility.	ARCHIVED
Cannabis THC / CBD	Cannabinoid	Pre-2019–Ongoing	Gateway compound. Initial portal that "cracked the door" per 1142 origin narrative. Studied as anxiety modulator and sleep regulation adjunct throughout all research phases.	ACTIVE
Mescaline Peyote / San Pedro cactus alkaloid	Phenethylamine	2021–2023	Documented for combo analysis (Holy Trinity: LSD + Mescaline + PCP). Long-duration serotonergic profile charted vs. LSD baseline. Visual geometry pattern analysis.	ARCHIVED
2C-B 4-Bromo-2,5-dimethoxyphenethylamine	Phenethylamine	2021–2022	Studied for dose-response curve clarity. Lower dissociative component vs. LSD. Documented for potential ADHD/autism adjunct protocol development.	ARCHIVED
Amphetamine Adderall / dextroamphetamine	Stimulant	2020–2021	Cross-comparison with methylphenidate for neurodivergent cognitive profiles. Key observation: distinct dopamine/norepinephrine ratio differences produce qualitatively different focus states. Documented in Blue Meth War context.	ARCHIVED
Ketamine Special K · C₁₃H₁₆ClNO	Dissociative	2022	NMDA receptor antagonism profiled against serotonergic baseline. Dissociative state documented for phenomenological comparison. Harm reduction protocol drafted for withdrawal scenarios.	ARCHIVED
Bupropion Wellbutrin · C₁₃H₁₈ClNO	NDRI	2021–2023	Studied as adjunct to methylphenidate. Dopamine/norepinephrine reuptake inhibition profiled for neurodivergent mood stabilization. Interaction with stimulant regimen documented.	ARCHIVED
Caffeine 1,3,7-trimethylxanthine	Xanthine	Ongoing	Documented as baseline stimulant. Interaction profiling with methylphenidate for timing and tolerance management. Control variable in multiple Brainstorm Nights sessions.	ACTIVE
PCP Phencyclidine	Dissociative	2022	Documented as component of Holy Trinity combo (LSD + Mescaline + PCP). Cartoonish visual geometry, shape transformations, and pinhole focus fluctuations recorded. High-friction harm reduction warnings issued.	ARCHIVED
Fentanyl Synthetic opioid · C₂₂H₂₈N₂O	Opioid	Harm Reduction	Studied exclusively from a harm reduction and withdrawal documentation perspective. The antagonist of the Blue Meth War ideology. Withdrawal timeline generator developed. NOT a 1142 research compound — included for community safety documentation.	HARM RED.

Research Log · Breakthrough Timeline

The Log

Key observations in chronological order. The living record of the 1142 research program.

December 22, 2019 · 11:42 PM

Entry 001 — The First 11:42

Solo 12-hour LSD session beginning exactly at 11:42 PM, concluding at 11:42 AM. Basement bachelor apartment, 18 years old, first lease. Something fundamentally shifts. The idea cannot be contained. 1142 Labs is born — not as a brand, as a rejection of every broken thing the world said to accept. Duration: 12 hours. Compound: LSD-25. Setting: Peterborough.

March 2020

Entry 002 — Brainstorm Nights Protocol

First structured research protocol established. LSD-25 + low-dose methylphenidate (Ritalin) in combination. Objective: creative exploration and real-time data capture. Finding: the stimulant prevents "scatter" during the psychedelic state — the user functions as an operator within their own mind. Creative output measurably enhanced vs. solo LSD sessions. First use of combined session documentation methodology.

July 2020

Entry 003 — 11-42.ca Goes Live

First digital manifestation of 1142. Site v1.0 launched as a repository for experience reports and psychedelic data. The movement has a URL. CFNY 102.1 The Edge (Toronto) references the project: "2 southern Ontario scientists are tripping out and testing the effects of acid on autism." First mainstream media acknowledgment. The underground goes above ground, briefly.

October 2020

Entry 004 — Medication Recalibration

High-dose methylphenidate regimen commenced. Key realization: neurodivergent cognitive needs differ fundamentally from the populations mainstream dosing guidelines were built for. The brain is an operating system. The medication is a software update. MPH Series paper development begins.

June 2021

Entry 005 — Oxidized Methylphenidate Theory (MPH-005)

Theory formalized: methylphenidate in an oxidized state may possess unique cognitive-enhancing properties when used during a psychedelic session. Specific: the chemical state of the molecule changes its interaction with neurotransmitter systems, producing a qualitatively distinct quality of clarity. "Visionary speed." Documented as MPH-005. One of the most technically speculative entries in the archive.

February 2022

Entry 006 — LSD Memory Archive Discovery (CS-001)

Observation: LSD functions as a tool for unlocking repressed traumatic memories and navigating deeply buried subconscious material. The brain stores trauma like digital files — LSD provides the access key. Sessions designed specifically around this model show consistent pattern: suppressed material becomes retrievable, emotionally processable, and integrable within 48 hours post-session. CS-001 formally written.

April 2023

Entry 007 — Global Ritual Expansion

The 11:42 ritual — drop at sunset on the 22nd, maintain for 12 hours — expands beyond solo practice to a globally synchronized movement. Participants in multiple locations, same temporal window. Hypothesis: collective synchronized psychedelic exploration yields higher-order insights than isolated sessions. The 11:42 becomes a form of distributed consciousness computing.

November 2023

Entry 008 — Prescription Reinstatement, Barrie

Successful public advocacy effort in Barrie, Ontario results in official medical recognition and reinstatement of prescription support. Validation of the 1142 approach to neurodivergent medication. A turning point — from underground to partially recognized. The movement enters a phase of stabilization.

January 2024

Entry 009 — Studied Substances Published

Comprehensive archive published documenting every psychoactive substance analyzed by 1142 Labs over five years of independent research. The chem log goes public. Every compound, every protocol, every harm reduction finding — accessible. The underground library opens its doors.

2020–2022 · Compound Series · Psilocybin

Entry 010 — Psilocybin Research Thread

Psilocybin sessions initiated as a complementary vector to LSD research. Key differentiator observed: psilocybin produces a more body-integrated, emotionally proximal state compared to LSD's cerebral architectural quality. Sessions consistently surface trauma-adjacent material with lower resistance than LSD — useful for grief processing. Katrina-dedicated sessions in this series produce the most significant emotional integration data of the entire archive. Duration range: 4–6 hours. Compound: Psilocybe cubensis, standardized doses. Setting: controlled indoor.

2021 · Compound Series · Mescaline

Entry 011 — Mescaline: The Long Burn

Mescaline sessions documented as part of the phenethylamine research thread. Duration: 10–12 hours, significantly longer than tryptamine-class psychedelics. Observation: mescaline produces a qualitatively distinct sensory augmentation — colors, textures, and sound processing are enhanced without the LSD tendency toward abstraction. Philosophical depth is high but remains grounded in the physical present. Noted as the most sociable of the primary research compounds — sessions with others produce collaborative insight rather than internal separation. Documented in the old site as: "Mescaline is a very powerful high."

2021 · Compound Series · DMT

Entry 012 — DMT: Rapid Extraction Protocol

DMT sessions conducted via vaporization. Duration: 8–15 minutes per session. Key observation: the compound produces a complete break from consensus reality within seconds — unlike any other compound in the 1142 research stack. The experience is not psychedelic in the traditional sense; it is categorical. Entities present in 4 of 6 documented sessions. Post-session clarity is immediate and total. Documented as potentially the highest-information-density experience per unit time of any compound in the stack. Concern logged: the rapid re-entry into baseline makes systematic data capture nearly impossible — a methodological challenge unique to this compound.

2022 · Compound Series · 2C-B

Entry 013 — 2C-B: The Bridge Compound

2C-B documented as uniquely positioned between phenethylamine and tryptamine character — a hybrid experience. Dose-sensitivity curve is steep: 15mg produces a mild entactogenic enhancement, 25mg produces a full psychedelic break comparable to 100µg LSD with significantly higher body-load. Duration: 4–5 hours. Finding: 2C-B is the most dose-controllable of the psychedelics in the stack — making it the most predictable for structured research sessions. Tagged in the old site archive as a novel compound profile. Classified internally as a "research bridge" — sessions used to anchor methodological continuity between heavier LSD and DMT sessions.

June 2024 · Infrastructure · Hardware

Entry 014 — Emergency RAID-6 Rebuild

Non-chemical entry — technical infrastructure. Full RAID-6 array failure detected. Emergency rebuild executed solo, without external support, under active system failure conditions. Result: zero data loss. Duration: ~14 hours continuous. This entry is logged because the server held five years of research documentation, session logs, and the original chemical database pre-dating the current site. Recovery was not optional. The hardware survived. The archive survived. The signal continues uninterrupted.

2025–2026 · Active · Toronto

Entry 015 — The Monthly Ritual: Current State

The 11:42 monthly ritual — 27th of every month, dose at sundown, 12-hour arc — remains active and uninterrupted. Current setting: Toronto. The ritual has now produced more than 60 documented cycle-entries across the full 1142 timeline. Each session generates structured notes, compound observations, and philosophical reflection documented into the living archive. The ritual is the engine. The lab is its exhaust. Compound: LSD-25, responsible use framework. Protocol: Brainstorm Nights variant — low-dose methylphenidate co-administration maintained for cognitive anchoring. Status: ONGOING.

Chem Log Archive

Core Compounds

Studied Substances

The Log